RxDoctor Payments Data

Gerald Fortuna, MD

Vascular Surgery · West Columbia, SCNPI 1447479829

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $88,900 of the $143,044 with a category attached, or 62.1%. Inari Medical, Inc. accounts for 93.6% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $61,639 and has fallen 98.1% since, to $1,152 in 2025. Among vascular surgery clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$143,044in general payments, 2019–2025

Across 244 payments — averaging $586.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$134K
  • Endologix LLC$2K
  • Cook Medical LLC$1K
  • Prytime Medical Devices, Inc.$1K
  • Medtronic$865
  • W. L. Gore & Associates, Inc.$796
  • plus $3K from 21 others
$34,681in research payments, 2019–2025

Across 14 payments — averaging $2477.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inari Medical, Inc.$14K
  • W. L. Gore & Associates, Inc.$10K
  • Medtronic$7K
  • Stryker$4K

What the payments were for

  • Consulting fees$88,90062%
  • Speaking & faculty fees$23,50016%
  • Grants$5,0003%
  • Travel & lodging$10,1127%
  • Food & beverage$14,91310%
  • Education$6200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$143,044 in reported general payments places this provider in the 90th percentile of 99 vascular surgery providers in South Carolina.

See all vascular surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$672,287
Medicare patients
1,507
Services billed
2,931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$18,430
BrilintaTicagrelor15$8,252
Cilostazol41$915
ClopidogrelClopidogrel Bisulfate26$479
Gabapentin13$360
Atorvastatin Calcium11$51

Paid to pharmacies, not to this prescriber.

Other vascular surgery in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →